Arq Bras Endocrinol Metab vol.50 número4

In about 25 percent of these patients followed without surgery over 10 years, guidelines for surgery were met eventually by virtue of an increasing serum or urinary calcium or

Out of 124 patients con- secutively seen at our institution, 47% presented with no symptoms related to the disease, while 25% presented with severe skeletal involvement and osteitis

Osteoporosis is a metabolic disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and

The reduction in blood pressure in the DASH diet, using dairy as the source of calcium, was approximately twice as great as had been previously found for calci- um carbonate

approach to the prevention and treatment of osteo- porosis, with a foundation of lifestyle changes that include nutrition, physical activity, and fall preven- tion; a second tier

Significant differential effects of alen- dronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of post- menopausal osteoporosis:

Bisphosphonate therapy normalizes bone turnover, reduces the number of bone remodeling sites and stress risers, restores the balance of bone remodeling, prevents bone loss

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis... Lindsay R, Silverman SL, Cooper C, Hanley